Please try another search
© Reuters.
By Yasin Ebrahim
Investing.com - The Dow fell Friday as worries about the economic recovery continue to mount after U.S. Treasury Secretary Steven Mnuchin said emergency lending programs that had steadied the economy during the pandemic would not be renewed.
The Dow Jones Industrial Average fell 0.0.53%, or 155 points. The S&P 500 was down 0.27%, while the Nasdaq Composite rose 0.08 %.
Mnuchin said late Thursday he does not plan to extend several crucial emergency lending programs when they expire at the end of year, raising worries about the outlook for the recovery.
The treasury secretary said the programs "have clearly achieved their objectives," but analysts questioned the timing of the move as Covid-19 cases continue to surge.
"(D)epending on the depth and duration of the second-round resurgence and the subsequent policy response, the U.S. economy could slow significantly or potentially fall back into negative territory, creating a second-round recession," Stifel said in a note.
U.S. coronavirus cases reached another daily high Thursday with 185,759 new infections, according to Johns Hopkins University data.
Against the growing backdrop of worries about the recovery, industrials, energy, and financials slipped, dragging the broader market deeper into the red.
Financials were hurt by regional banks, with W. R. Berkley (NYSE:WRB), Citizens Financial Group (NYSE:CFG) and Regions Financial (NYSE:RF) down more than 2%. A slip in U.S. Treasury yields, with the United States 10-Year TIPS falling 2%, exacerbated weakness in banks.
Energy, meanwhile, shrugged off firmer oil prices, paced by a decline in Devon Energy (NYSE:DVN) and Marathon Oil (NYSE:MRO).
Elsewhere, stay-at-home stocks like Peloton Interactive (NASDAQ:PTON) and Zoom Video Communications (NASDAQ:ZM) rose, with the latter up more than 6% as investors bet that further restrictions will keep demand elevated.
On the vaccine front, Pfizer (NYSE:PFE) rose more than 1% after confirming it would apply on Friday for emergency use authorization for its Covid-19 vaccine. The U.S. Food and Drug Administration is expected to review the request in the coming weeks, and the vaccine, if approved, is expected to be rolled out before year-end.
In other news, Boeing (NYSE:BA) was down 1% even as reports suggested the 737 Max is nearing approval in Europe.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.